Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVersarien Regulatory News (VRS)

  • This share is currently suspended. It was suspended at a price of 0.01
  • There is currently no data for VRS

Acquisition

3 Feb 2015 14:00

RNS Number : 9287D
Versarien PLC
03 February 2015
 



3 February 2015

Versarien plc

 

("Versarien plc" or the "Company")

 

 

Acquisition of the business and certain assets of Custom Systems Limited

 

Management identifies considerable synergies for Versarien's

copper foam business

 

 

Versarien plc (AIM:VRS.L), the advanced engineering materials group, is pleased to announce that it has acquired out of administration the business and a majority of the assets of Custom Systems Limited ("CSL") for an initial cash consideration of £206,000. The acquisition provides both companies with a number of synergies.

 

Based in Avonmouth near Bristol, CSL is a manufacturer of all manner of extruded aluminum products, and heat sinks for the electronics and computing industries as well as for large machinery and generators.

 

Together, the businesses are able to offer a wider range of thermal products. The acquisition also gives Versarien access to CSL's prestigious customer base and will provide potential new routes to market for Versarien Technologies' recently developed porous copper air heat sink products.

 

Following completion CSL's operations and manufacturing facilities will be relocated to Versarien's headquarters in Mitcheldean, Gloucestershire. This will provide both business with operating efficiencies and increased sales coverage.

 

In the year ended 31 December 2014 CSL recorded sales of £3.6 million (FY 2013: £2.9m) with operating losses of £187,000. Of this approximately 60% of sales related to aluminum extrusions and heat sink products.

 

Details of acquisition

In addition to the plant and stock and all rights pertaining to the business, Versarien has also acquired over 90% of the current sales order book relating to aluminum extrusions and heatsinks, amounting to approximately £400,000.

 

The initial consideration is subject to a post-completion adjustment based upon the agreed stock level and the agreed order book at completion. Any adjustment is not expected to be material, and will be satisfied by a single cash payment within three months of completion.

 

Neill Ricketts, CEO of Versarien said: "This is an important acquisition which fits well with our strategy to provide customers with a range of standard and customer specific thermal products, including our patented porous metal foam technology.

 

"Our further aim is to preserve the maximum number of jobs we can and we look forward to welcoming our new colleagues into the team and sharing our expertise and industry knowledge. CSL's customers can be assured of a continuation of the high level of service they have come to expect, as well as the opportunity to access an expanded range of products."

 

 

 

For further information:

Versarien Plc

Neill Ricketts, Chief Executive Officer

Tel: +44 (0) 1594 888 622

Chris Leigh, Chief Financial Officer

www.versarien.com

 

Charles Stanley Securities

Nominated Adviser and Broker

Mark Taylor / Russell Cook

Tel: +44 (0) 20 7149 6000

 

Media enquiries:

Abchurch Communications Limited

Henry Harrison-Topham / Jamie Hooper

Tel: +44 (0) 20 7398 7702

versarien@abchurch-group.com

www.abchurch-group.com

 

 

 

Notes to Editors

 

Versarien plc(AIM:VRS), is an advanced engineering materials group. Leveraging proprietary technology, the Group creates innovative engineering solutions for its clients in a diverse range of industries. Versarien has two wholly owned subsidiaries, Versarien Technologies Ltd and Total Carbide Ltd, and holds an 85% stake in 2-DTech Ltd.

 

Versarien Technologies Limited ("VTL")

VTL owns the exclusive rights to a patent-protected additive process for creating advanced micro-porous metals. Versarien primarily targets the thermal management industry exploiting the superb thermal properties exhibited by such materials. The company's lead product is VersarienCu, a micro-porous copper which on incorporation into liquid cooling systems, can improve efficiency by up to ten times. http://www.versarien.co.uk/

 

2-DTech Limited

On 1 May 2014, Versarien acquired 85% of the issued share capital of 2-DTech, a company closely aligned with The University of Manchester, the established home of graphene technology. 2-DTech specialises in the supply, characterisation and early stage development of graphene products. 2-DTech also works closely with industry and researchers to help turn scientific innovation into groundbreaking products. The acquisition will enable Versarien to apply its experience and expertise to commercialising graphene in the UK; demand for which is set to grow exponentially over the coming years. For further information about 2-DTech visit http://2-dtech.com/

 

Total Carbide Limited ("TC")

TC is one of the leading European manufacturers of sintered tungsten carbide, with a global customer base covering over forty different industries. It primarily manufactures arduous environment products for application in the oil and gas industry, along with multiple other industries. TC provides VTL with access to high volume manufacturing assets that have significantly expanded production of VersarienCu. http://www.totalcarbide.com/

 

 

 

-Ends-

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQLLFEVFEIVIIE
Date   Source Headline
9th Feb 20267:00 amRNSCancellation - Versarien Plc
6th Jan 20261:34 pmRNSAppointment of Administrators
19th Dec 20254:36 pmRNSUpdate on NOIA
19th Dec 20254:36 pmRNSUpdate on NOIA
15th Dec 20253:53 pmRNSUpdate on the Disposal of AAC Cyroma Limited
12th Dec 20257:00 amRNSUpdate on NOIA and Change of Registered Office
1st Dec 20257:30 amRNSSuspension - Versarien plc
1st Dec 20257:00 amRNSIntention to Appoint Administrators, Suspension
26th Nov 20257:00 amRNSUpdate - Proposed Disposal of the Company's Assets
31st Oct 20258:48 amRNSProposed Disposal of the Company’s Assets
29th Sep 20252:32 pmRNSCorporate Update
10th Sep 20251:00 pmRNSCorporate Update
29th Aug 20252:19 pmRNSCorporate Update
21st Aug 20257:00 amRNSStrategic Investment and Joint Venture Update
11th Aug 20257:00 amRNSCorporate Update
5th Aug 202511:03 amRNSHolding(s) in Company
29th Jul 20257:00 amRNSCorporate Update
22nd Jul 202510:55 amRNSSettlement of Legal Claims
4th Jul 20257:00 amRNS-RSouth American Polygrene™ Themoplastics Agreements
30th Jun 20253:03 pmRNSInterim Results
19th Jun 20252:34 pmRNSBuilding for Humanity – Contract Update
4th Jun 202511:49 amRNSHolding(s) in Company
2nd Jun 20252:03 pmRNSHolding(s) in Company
30th May 202510:19 amRNSHolding(s) in Company
30th May 20257:00 amRNSTotal Voting Rights
29th May 20253:29 pmRNSHolding(s) in Company
29th May 202510:20 amRNSHolding(s) in Company
27th May 202511:59 amRNSHolding(s) in Company
27th May 202511:02 amRNSHolding(s) in Company
23rd May 20259:38 amRNSHolding(s) in Company
22nd May 202511:56 amRNSHolding(s) in Company
21st May 202510:58 amRNSHolding(s) in Company
20th May 202511:11 amRNSHolding(s) in Company
14th May 20257:00 amRNSPlacing to raise £425,000
2nd May 202511:00 amRNSUpdate on Legal Claims
28th Apr 20251:04 pmRNSResult of AGM
27th Mar 20257:00 amRNSAudited Results for year ended 30 September 2024
24th Mar 202511:24 amRNSResult of General Meeting
10th Mar 20257:00 amRNS-RGraphinks™ supply agreement with Montana Química
5th Mar 20257:00 amRNSNotice of General Meeting
3rd Mar 20257:00 amRNSCompletion of Sale of Korean Assets
28th Feb 20257:00 amRNSTotal Voting Rights
27th Feb 20257:00 amRNSInnovate UK Loan Deed of Variation
10th Feb 20258:35 amRNSHolding(s) in Company
28th Jan 20252:36 pmRNSPlacing to raise £246k
30th Dec 202412:00 pmRNSUpdate on Sale of Korean Assets
13th Dec 20242:58 pmRNSHolding(s) in Company
13th Dec 202411:50 amRNSHolding(s) in Company
13th Dec 202410:11 amRNSHolding(s) in Company
13th Dec 20247:00 amRNS€804,000 Grant Award

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.